Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Coppin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biologics : Targets & Therapy|June 10, 2010
Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenibChris Coppin
Biologics : Targets & Therapy|August 27, 2009
Sunitinib for advanced renal cell cancerChris Coppin
Expert Review of Anticancer Therapy|June 7, 2008
Immunotherapy for renal cell cancer in the era of targeted therapyChris Coppin
BJU International|September 29, 2011
Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trialsChris Coppin, Christian Kollmannsberger, Lyly Le, et al.
Journal of Molecular Evolution|June 19, 2009
Birth and death of genes and functions in the beta-esterase cluster of DrosophilaCharles Robin, Lisa M J Bardsley, Chris Coppin, et al.
Genome Biology and Evolution|March 24, 2025
Transcriptomic Temperature Stress Responses Show Differentiation Between Biomes for Diverse PlantsSamuel C Andrew, Rosalie J Harris, Chris Coppin, et al.
The Journal of Urology|November 11, 2005
Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British ColumbiaAbdulwahab J Al-Tourah, Nevin Murray, Chris Coppin, et al.
The Annals of Thoracic Surgery|October 26, 2005
Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valveTakeyoshi Ota, Yoshiki Sawa, Shigemitsu Iwai, et al.
American Journal of Clinical Oncology|October 24, 2002
Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tractHuda A Al-Karim, Kennard E Tan, Kim N Chi, et al.
Assay and Drug Development Technologies|November 6, 2010
Using a genetically encoded fluorescent amino acid as a site-specific probe to detect binding of low-molecular-weight compoundsIsaac N Ugwumba, Kiyoshi Ozawa, Laura de la Cruz, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biologics : Targets & Therapy|June 10, 2010
Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenibChris Coppin
Biologics : Targets & Therapy|August 27, 2009
Sunitinib for advanced renal cell cancerChris Coppin
Expert Review of Anticancer Therapy|June 7, 2008
Immunotherapy for renal cell cancer in the era of targeted therapyChris Coppin
BJU International|September 29, 2011
Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trialsChris Coppin, Christian Kollmannsberger, Lyly Le, et al.
Journal of Molecular Evolution|June 19, 2009
Birth and death of genes and functions in the beta-esterase cluster of DrosophilaCharles Robin, Lisa M J Bardsley, Chris Coppin, et al.
Genome Biology and Evolution|March 24, 2025
Transcriptomic Temperature Stress Responses Show Differentiation Between Biomes for Diverse PlantsSamuel C Andrew, Rosalie J Harris, Chris Coppin, et al.
The Journal of Urology|November 11, 2005
Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British ColumbiaAbdulwahab J Al-Tourah, Nevin Murray, Chris Coppin, et al.
The Annals of Thoracic Surgery|October 26, 2005
Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valveTakeyoshi Ota, Yoshiki Sawa, Shigemitsu Iwai, et al.
American Journal of Clinical Oncology|October 24, 2002
Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tractHuda A Al-Karim, Kennard E Tan, Kim N Chi, et al.
Assay and Drug Development Technologies|November 6, 2010
Using a genetically encoded fluorescent amino acid as a site-specific probe to detect binding of low-molecular-weight compoundsIsaac N Ugwumba, Kiyoshi Ozawa, Laura de la Cruz, et al.
Pageof 2